Atlanticus Prices $50 Million Offering of Senior Notes
ATLANTA, Jan. 26, 2024 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a […]
Phunware Appoints Industry Veteran Elliot Han to its Board of Directors
AUSTIN, Texas, Jan. 26, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), the leading provider of patented wayfinding […]
WiMi Developed An AI-driven Real-time Spatial Interaction Perception System for Interior Design
Beijing, Jan. 26, 2024 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]
ParaZero Has Enabled Precedent-Setting Light UAS Operator Certificate Approval in Denmark
The light UAS operator certificate (LUC) approval allows for self-authorized cross-border drone operations throughout the European Union without additional approval […]
AppTech Payments Announces Strategic Partnership with First Inning Ventures to Expand Commerse™ Suite in the International and Domestic Sports Market
CARLSBAD, Calif., Jan. 26, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company […]
DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024
BOSTON, Jan. 26, 2024 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will […]
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
Q3W schedule of CRB-701 (SYS6002) demonstrates a 43% ORR and 71% DCR at predicted therapeutically relevant doses All assessable nectin-4 […]
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), […]
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal […]
South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results
LUBBOCK, Texas, Jan. 26, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent […]
